Your browser doesn't support javascript.
loading
Geographical distribution and prevalence of podoconiosis in Rwanda: a cross-sectional country-wide survey.
Deribe, Kebede; Mbituyumuremyi, Aimable; Cano, Jorge; Jean Bosco, Mbonigaba; Giorgi, Emanuele; Ruberanziza, Eugene; Bayisenge, Ursin; Leonard, Uwayezu; Bikorimana, Jean Paul; Rucogoza, Aniceth; Turate, Innocent; Rusanganwa, Andre; Pigott, David M; Pullan, Rachel L; Noor, Abdisalan M; Enquselassie, Fikre; Condo, Jeanine U; Murray, Christopher J L; Brooker, Simon J; Hay, Simon I; Newport, Melanie J; Davey, Gail.
Afiliación
  • Deribe K; Wellcome Trust Brighton and Sussex Centre for Global Health Research, Brighton and Sussex Medical School, Brighton, UK; School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia. Electronic address: k.deribe@bsms.ac.uk.
  • Mbituyumuremyi A; Malaria and Other Parasitic Disease Division, Rwanda Biomedical Center-Ministry of Health, Kigali, Rwanda.
  • Cano J; Department of Disease Control, London School of Hygiene & Tropical Medicine, London, UK.
  • Jean Bosco M; Malaria and Other Parasitic Disease Division, Rwanda Biomedical Center-Ministry of Health, Kigali, Rwanda.
  • Giorgi E; Department of Disease Control, London School of Hygiene & Tropical Medicine, London, UK; Lancaster Medical School, Faculty of Health and Medicine, Lancaster University, Lancaster, UK.
  • Ruberanziza E; Malaria and Other Parasitic Disease Division, Rwanda Biomedical Center-Ministry of Health, Kigali, Rwanda.
  • Bayisenge U; Malaria and Other Parasitic Disease Division, Rwanda Biomedical Center-Ministry of Health, Kigali, Rwanda.
  • Leonard U; Byumba Hospital, Kibali, Rwanda.
  • Bikorimana JP; Heart and Sole Africa in Ruhengeri, Musanze, Rwanda.
  • Rucogoza A; National Reference Laboratory, Rwanda Biomedical Center, Kigali, Rwanda.
  • Turate I; Institute of HIV/AIDS, Disease Control and Prevention Department, Rwanda Biomedical Center, Kigali, Rwanda.
  • Rusanganwa A; World Health Organization, Rwanda Country Office, Kigali, Rwanda.
  • Pigott DM; Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
  • Pullan RL; Department of Disease Control, London School of Hygiene & Tropical Medicine, London, UK.
  • Noor AM; Kenya Medical Research Institute-Wellcome Trust Collaborative Programme, Nairobi, Kenya; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, UK.
  • Enquselassie F; School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia.
  • Condo JU; Malaria and Other Parasitic Disease Division, Rwanda Biomedical Center-Ministry of Health, Kigali, Rwanda.
  • Murray CJL; Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
  • Brooker SJ; Bill & Melinda Gates Foundation, Seattle, WA, USA.
  • Hay SI; Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
  • Newport MJ; Wellcome Trust Brighton and Sussex Centre for Global Health Research, Brighton and Sussex Medical School, Brighton, UK.
  • Davey G; Wellcome Trust Brighton and Sussex Centre for Global Health Research, Brighton and Sussex Medical School, Brighton, UK; School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia.
Lancet Glob Health ; 7(5): e671-e680, 2019 05.
Article en En | MEDLINE | ID: mdl-30926303
ABSTRACT

BACKGROUND:

Podoconiosis is a type of tropical lymphoedema that causes massive swelling of the lower limbs. The disease is associated with both economic insecurity, due to long-term morbidity-related loss of productivity, and intense social stigma. Reliable and detailed data on the prevalence and distribution of podoconiosis are scarce. We aimed to fill this data gap by doing a nationwide community-based study to estimate the number of cases throughout Rwanda.

METHODS:

We did a population-based cross-sectional survey to determine the national prevalence of podoconiosis. A podoconiosis case was defined as a person with bilateral, asymmetrical lymphoedema of the lower limb present for more than 1 year, who tested negative for Wuchereria bancrofti antigen (determined by Filariasis Test Strip) and specific IgG4 (determined by Wb123 test), and had a history of any of the associated clinical signs and symptoms. All adults (aged ≥15 years) who resided in any of the 30 districts of Rwanda for 10 or more years were invited at the household level to participate. Participants were interviewed and given a physical examination before Filariasis Test Strip and Wb123 testing. We fitted a binomial mixed model combining the site-level podoconiosis prevalence with continuous environmental covariates to estimate prevalence at unsampled locations. We report estimates of cases by district combining our mean predicted prevalence and a contemporary gridded map of estimated population density.

FINDINGS:

Between June 12, and July 28, 2017, 1 360 612 individuals-719 730 (53%) women and 640 882 (47%) men-were screened from 80 clusters in 30 districts across Rwanda. 1143 individuals with lymphoedema were identified, of whom 914 (80%) had confirmed podoconiosis, based on the standardised diagnostic algorithm. The overall prevalence of podoconiosis was 68·5 per 100 000 people (95% CI 41·0-109·7). Podoconiosis was found to be widespread in Rwanda. District-level prevalence ranged from 28·3 per 100 000 people (16·8-45·5, Nyarugenge, Kigali province) to 119·2 per 100 000 people (59·9-216·2, Nyamasheke, West province). Prevalence was highest in districts in the North and West provinces Nyamasheke, Rusizi, Musanze, Nyabihu, Nyaruguru, Burera, and Rubavu. We estimate that 6429 (95% CI 3938-10 088) people live with podoconiosis across Rwanda.

INTERPRETATION:

Despite relatively low prevalence, podoconiosis is widely distributed geographically throughout Rwanda. Many patients are likely to be undiagnosed and morbidity management is scarce. Targeted interventions through a well coordinated health system response are needed to manage those affected. Our findings should inform national level planning, monitoring, and implementation of interventions.

FUNDING:

Wellcome Trust.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Elefantiasis Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Africa Idioma: En Revista: Lancet Glob Health Año: 2019 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Elefantiasis Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Africa Idioma: En Revista: Lancet Glob Health Año: 2019 Tipo del documento: Article